BINDING OF OLIGOGUANYLATE TO SCAVENGER RECEPTORS IS REQUIRED FOR OLIGONUCLEOTIDES TO AUGMENT NK CELL-ACTIVITY AND INDUCE IFN

被引:104
作者
KIMURA, Y
SONEHARA, K
KURAMOTO, E
MAKINO, T
YAMAMOTO, S
YAMAMOTO, T
KATAOKA, T
TOKUNAGA, T
机构
[1] MITSUI TOATSU CHEM CO LTD,LIFE SCI RES LABS,MOBARA,CHIBA 297,JAPAN
[2] NATL INST HLTH,TOKYO 208,JAPAN
关键词
INTERFERON; NATURAL KILLER; OLIGONUCLEOTIDE; PALINDROMIC SEQUENCE; SCAVENGER RECEPTOR;
D O I
10.1093/oxfordjournals.jbchem.a124658
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Specific palindromic sequences in synthetic oligonucleotides are required to induce IFN and augment IFN-mediated natural killer activity. To study the mechanism of IFN induction by oligonucleotides containing palindromic sequences, we investigated the possible target molecules of the oligonucleotides. Oligo-1, a 30mer single-stranded oligonucleotide with oligoG sequences next to the active palindromic sequence (AACGTT), had more activity than oligonucleotides with oligoA, oligoC, or oligoT sequences. The activity of oligo-1 was inhibited by a guanine homo-oligomer (G30), dextran sulfate, and polyvinyl sulfate. Oligo-1 bound to plastic-adherent mouse splenocytes, and the binding was inhibited by G30, dextran sulfate, and polyvinyl sulfate. Oligo-1 inhibited acetyl-LDL binding to the scavenger receptor on mouse splenocytes. These findings suggest that the binding of an extrapalindromic sequence to the scavenger receptor is required for the immunostimulatory activity of oligo-1.
引用
收藏
页码:991 / 994
页数:4
相关论文
共 21 条
[11]   OLIGONUCLEOTIDE SEQUENCES REQUIRED FOR NATURAL-KILLER-CELL ACTIVATION [J].
KURAMOTO, E ;
YANO, O ;
KIMURA, Y ;
BABA, M ;
MAKINO, T ;
YAMAMOTO, S ;
YAMAMOTO, T ;
KATAOKA, T ;
TOKUNAGA, T .
JAPANESE JOURNAL OF CANCER RESEARCH, 1992, 83 (11) :1128-1131
[12]  
MANIATIS T, 1982, MOL CLONING LABORATO, P117
[13]   INVITRO AUGMENTATION OF NATURAL-KILLER ACTIVITY OF PERIPHERAL-BLOOD CELLS FROM CANCER-PATIENTS BY A DNA FRACTION FROM MYCOBACTERIUM-BOVIS BCG [J].
MASHIBA, H ;
MATSUNAGA, K ;
TOMODA, H ;
FURUSAWA, M ;
JIMI, S ;
TOKUNAGA, T .
JAPANESE JOURNAL OF MEDICAL SCIENCE & BIOLOGY, 1988, 41 (5-6) :197-202
[14]   HUMAN MACROPHAGE SCAVENGER RECEPTORS - PRIMARY STRUCTURE, EXPRESSION, AND LOCALIZATION IN ATHEROSCLEROTIC LESIONS [J].
MATSUMOTO, A ;
NAITO, M ;
ITAKURA, H ;
IKEMOTO, S ;
ASAOKA, H ;
HAYAKAWA, I ;
KANAMORI, H ;
ABURATANI, H ;
TAKAKU, F ;
SUZUKI, H ;
KOBARI, Y ;
MIYAI, T ;
TAKAHASHI, K ;
COHEN, EH ;
WYDRO, R ;
HOUSMAN, DE ;
KODAMA, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (23) :9133-9137
[15]   PLATELET SECRETORY PRODUCTS INHIBIT LIPOPROTEIN METABOLISM IN MACROPHAGES [J].
PHILLIPS, DR ;
ARNOLD, K ;
INNERARITY, TL .
NATURE, 1985, 316 (6030) :746-748
[16]  
SHIMADA S, 1986, JPN J CANCER RES, V77, P808
[17]  
SHIMADA S, 1985, J NATL CANCER I, V74, P681
[18]  
TOKUNAGA T, 1984, J NATL CANCER I, V72, P955
[19]   SYNTHETIC OLIGONUCLEOTIDES WITH PARTICULAR BASE SEQUENCES FROM THE CDNA-ENCODING PROTEINS OF MYCOBACTERIUM-BOVIS BCG INDUCE INTERFERONS AND ACTIVATE NATURAL-KILLER-CELLS [J].
TOKUNAGA, T ;
YANO, O ;
KURAMOTO, E ;
KIMURA, Y ;
YAMAMOTO, T ;
KATAOKA, T ;
YAMAMOTO, S .
MICROBIOLOGY AND IMMUNOLOGY, 1992, 36 (01) :55-66
[20]   INVITRO AUGMENTATION OF NATURAL-KILLER CELL-ACTIVITY AND PRODUCTION OF INTERFERON-ALPHA-BETA AND INTERFERON-GAMMA WITH DEOXYRIBONUCLEIC-ACID FRACTION FROM MYCOBACTERIUM-BOVIS BCG [J].
YAMAMOTO, S ;
KURAMOTO, E ;
SHIMADA, S ;
TOKUNAGA, T .
JAPANESE JOURNAL OF CANCER RESEARCH, 1988, 79 (07) :866-873